Antibody Screening & Identification Panels (in Immunohematology)

 


1. Objective:
To detect and identify unexpected antibodies in a patient’s serum that may react with red blood cell antigens, especially before transfusion.

siza

2. Principle:
Patient serum is mixed with reagent red cells of known antigen profiles. Agglutination indicates the presence of antibodies. Identification involves comparing reaction patterns with known antigen matrices.

3. Materials:

  • Patient serum/plasma

  • Screening and identification red cell panels

  • LISS or saline

  • Antiglobulin reagent (Coombs reagent)

  • Test tubes or gel cards

  • Centrifuge, incubator

4. Procedure:

  1. Mix patient serum with screening cells → incubate.

  2. Wash to remove unbound antibodies.

  3. Add antihuman globulin → check for agglutination.

  4. If positive, proceed to identification with an extended red cell panel.

  5. Compare agglutination pattern to known antigen profiles.

5. Result Interpretation:

  • No agglutination: No detectable antibodies.

  • Agglutination with specific cells: Suggests presence of particular antibody (e.g., anti-D, anti-K, etc.).

6. Clinical Significance:

  • Crucial in transfusion safety.

  • Prevents hemolytic transfusion reactions.

  • Used in prenatal testing for HDFN (Hemolytic Disease of the Fetus and Newborn).


Comments

Popular posts from this blog

Coombs Test (Antiglobulin Test), including both the Direct and Indirect versions

Urine Culture

Antiphospholipid Antibody Test (e.g., dRVVT)